Stress increases vulnerability to inflammation in the rat prefrontal cortex

Journal of Neuroscience

Volumn 26, Issue 21, 2006, Pages 5709-5719

  De Pablos, R M ^a   Villaran R F ^a   Arguelles S ^a   Herrera, A J ^a   Venero, J L ^a   Ayala, A ^a   Cano, J ^a   Machado, A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

BDNF; Inflammation; MAP kinases; Neuronal death; Prefrontal cortex; Stress

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BINDING PROTEIN; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID RECEPTOR; GLUTAMATE DECARBOXYLASE 67; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NUCLEAR PROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; NERVE PROTEIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DNA RESPONSIVE ELEMENT; DRUG EFFECT; ENCEPHALITIS; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INFLAMMATION; MACROGLIA; MALE; MICROGLIA; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; WEIGHT CHANGE; ANIMAL; CHEMICALLY INDUCED DISORDER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; DISEASE SUSCEPTIBILITY; ENCEPHALITIS; LIPOPOLYSACCHARIDES; MALE; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; STRESS;

EID: 33744970277     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0802-06.2006     Document Type: Article

References (97)

1. Abekawa T, Ohmori T, Ito K, Koyama T (2000) D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex. Brain Res 867:250-254.
2. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, et al. (2000) Inflammation and Alzheimer disease. Neurobiol Aging 21:383-421.
3. Arnsten AF (1998) The biology of being frazzled. Science 280:1711-1712.
4. Behl C, Trapp T, Skutella T, Holsboer F (1997a) Protection against oxidative stress-induced neuronal cell death - a novel role for RU486. Eur J Neurosci 9:912-920.
5. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F (1997b) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101-106.
6. Belanoff JK, Gross K, Yager A, Schatzberg AF (2001) Corticosteroids and cognition. J Psychiatr Res 35:127-145.
7. Belanoff JK, Jurik J, Schatzberg LD, DeBattista C, Schatzberg AF (2002) Slowing the progression of cognitive decline in Alzheimer's disease using RU486. J Mol Neurosci 19:201-206.
8. Benveniste EN, Sparacio SM, Norris JG, Grenett HE, Fuller GM (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J Neuroimmunol 30:201-212.
9. Brazil DP, Hemmings BA (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26:657-664.
10. Carpenter SE, Santanam N, Murphy AA, Rock JA, Parthasarathy S (1996) Inhibition of oxidative modification of proteins by RU486. Fertil Steril 66:90-94.
11. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
12. Chao CC, Hu S, Peterson PK (1995) Glia, cytokines and neurotoxicity. Crit Rev Neurobiol 9:189-205.
13. Chung IY, Benveniste EN (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144:2999-3007.
14. Craft TK, Glasper ER, McCullough L, Zhang N, Sugo N, Otsuka T, Hurn PD, DeVries AC (2005) Social interaction improves experimental stroke outcome. Stroke 36:2006-2011.
15. DeBattista C, Belanoff J (2005) C-1073 (RU486) in the adjunctive treatment of Alzheimer's disease. Curr Alzheimer Res 2:125-129.
16. de Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR, Hock C, Nitsch RM, Mohajeri MH, Papassotiropoulos A (2004) Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet 13:47-52.
17. Elliott EM, Sapolsky RM (1993) Corticosterone impairs hippocampal neuronal calcium regulation: possible mediating mechanisms. Brain Res 602:84-90.
18. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylases. Neuron 7:91-100.
19. Feenstra MG, Botterblom MH, van Uum JF (1998) Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors. J Neurochem 70:1104-1113.
20. Felderhoff-Mueser U, Sifringer M, Pesditschek S, Kuckuck H, Moysich A, Bittigau P, Ikonomidou C (2002) Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis 11:231-245.
21. Fryer HJ, Davis GE, Manthorpe M, Varon S (1986) Lowry protein assay using an automatic microtiter plate spectrophotometer. Anal Biochem 153:262-266.
22. Gamaro GD, Manoli LP, Torres IL, Silveira R, Dalmaz C (2003) Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem Int 42:107-114.
23. Gerrits M, Westenbroek C, Fokkema DS, Jongsma ME, Den Boer JA, Ter Horst GJ (2003) Increased stress vulnerability after a prefrontal cortex lesion in female rats. Brain Res Bull 61:627-635.
24. Gilad GM, Gilad VH, Wyatt RJ, Tizabi Y (1990) Region-selective stress-induced increase of glutamate uptake and release in rat forebrain. Brain Res 525:335-338.
25. Glezer I, Munhoz CD, Kawamoto EM, Marcourakis T, Avellar MC, Scavone C (2003) MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. Neuropharmacology 45:1120-1129.
26. Harvey BH, Oosthuizen F, Brand L, Wegener G, Stein DJ (2004) Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology (Berl) 175:494-502.
27. Heese K, Otten U, Mathivet P, Raiteri M, Marescaux C, Bernasconi R (2000) GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology 39:449-462.
28. Herrera AJ, Machado A, Cano J (1993) Ageing and monoamine turnover in the lateral geniculate nucleus and visual cortex of the rat. Neurochem Int 22:531-539.
29. Herrera AJ, Castaño A, Venero JL, Cano J, Machado A (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429-447.
30. Hortnagl H, Berger ML, Havelec L, Hornykiewicz O (1993) Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by Ethylcholine Aziridinium (AF64A). J Neurosci 13:2939-2945.
31. Jedema HP, Moghaddam B (1996) Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats. J Neurochem 66:1448-1453.
32. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS (1998) Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10.
33. Karreman M, Moghaddam B (1996) Effect of a pharmacological stressor on glutamate efflux in the prefrontal cortex. Brain Res 716:180-182.
34. Kendler KS, Karkowski-Shuman L (1997) Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychol Med 27:539-547.
35. Kim SH, Won SJ, Sohn S, Kwon HJ, Lee JY, Park JH, Gwag BJ (2002) Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase. J Cell Biol 159:821-831.
36. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309-6316.
37. Koh JY, Gwag BJ, Lobner D, Choi DW (1995) Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268:573-575.
38. Konarska M, Stewart RE, McCarty R (1990) Predictability of chronic intermittent stress: effects on sympathetic-adrenal medullary responses of laboratory rats. Behav Neural Biol 53:231-243.
39. Krugers HJ, Knollema S, Kemper RH, Ter Horst GJ, Korf J (1995) Down-regulation of the hypothalamo-pituitary-adrenal axis reduces brain damage and number of seizures following hypoxia/ischaemia in rats. Brain Res 690:41-47.
40. Krugers HJ, Kemper RH, Korf J, Ter Horst GJ, Knollema S (1998) Metyrapone reduces rat brain damage and seizures after hypoxia-ischemia: an effect independent of modulation of plasma corticosterone levels? J Cereb Blood Flow Metab 18:386-390.
41. Krugers HJ, Maslam S, Van Vuuren SM, Korf J, Joels M (1999) Postischemic steroid modulation: effects on hippocampal neuronal integrity and synaptic plasticity. J Cereb Blood Flow Metab 19:1072-1082.
42. Kuipers SD, Trentani A, Den Boer JA, Ter Horst GJ (2003) Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 85:1312-1323.
43. Kuppers E, Beyer C (2001) Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. NeuroReport 12:1175-1179.
44. Lee da Y, Oh YJ, Jin BK (2005) Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways. Glia. 51:98-110.
45. Lee SC, Dickson DW, Liu W, Brosnan CF (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccgaride and IL-1β. J Immunol 150:2659-2667.
46. Li Q, Clark S, Lewis DV, Wilson WA (2002) NMDA receptor antagonists disinhibit rat posterior cingulated and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 22:3070-3080.
47. Lieberman AP, Pitha PM, Shin HS, Shin ML (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348-6352.
48. Liu J, Wang X, Shigenaga MK, Yeo HC, Mori A, Ames BN (1996) Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. FASEB J 10:1532-1538.
49. Marmigere F, Rage F, Tapia-Arancibia L (2003) GABA-glutamate interaction in the control of BDNF expression in hypothalamic neurons. Neurochem Int 42:353-358.
50. Matsumoto M, Togashi H, Kaku A, Kanno M, Tahara K, Yoshioka M (2005) Cortical GABAergic regulation of dopaminergic responses to psychological stress in the rat dorsolateral striatum. Synapse 56:117-121.
51. Mazure CM, Kincare P, Schaffer CE (1995) DSM-III-R Axis IV: clinician reliability and comparability to patients' reports of stressor severity. Psychiatry 58:56-64.
52. McCullers DL, Sullivan PG, Sheff SW, Hermen JP (2002) RU486 protects CA1 hippocampal neurons following traumatic brain injury in rat. Neuroscience 109:219-230.
53. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886:172-189.
54. McEwen BS (2002) Protective and damaging effects of stress mediators: the good and bad sides of the response to stress. Metabolism 51:2-4.
55. McGeer PL, McGeer EG (2004) Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 1035:104-116.
56. McIntosh LJ, Sapolsky RM (1996) Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology 17:873-882.
57. McIntosh LJ, Cortopassi KM, Sapolsky RM (1998) Glucocorticoids may alter antioxidant enzyme capacity in the brain: kainic acid studies. Brain Res 791:215-222.
58. Meltzer JC, Sanders V, Grimm PC, Stern E, Rivier C, Lee S, Rennie SL, Gietz RD, Hole AK, Watson PH, Greenberg AH, Nance DM (1998) Production of digoxigenin-labelled RNA probes and the detection of cytokina mRNA in rat spleen and brain by in situ hybridization. Brain Res Brain Res Protoc 2:339-351.
59. Moghaddam B (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60:1650-1657.
60. Morse JK, Davis JN (1990) Regulation of ischemic hippocampal damage in the gerbil: adrenalectomy alters the rate of CA1 cell disappearance. Exp Neurol 110:86-92.
61. Murua VS, Molina VA (1992) Effects of chronic variable stress and antidepressant drugs on behavioral inactivity during an uncontrollable stress: interaction between both treatments. Behav Neural Biol 57:87-89.
62. Muscat R, Papp M, Willner P (1992) Reversal of stress-induced anhedonia by the atypiacal antidepressants, fluoxetine and maprotiline. Psychopharmacology 106:821-826.
63. Oishi K, Yokoi M, Maekawa S, Sodeyama C, Shiraishi T, Kondo R, Kuriyama T, Machida K (1999) Oxidative stress and haematological changes in immobilized rats. Acta Physiol Scand 165:65-69.
64. Packan DR, Sapolsky RM (1990) Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 51:613-618.
65. Papp M, Willner P, Muscat R (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 104:255-259.
66. Parthasarathy S, Morales AJ, Murphy AA (1994) Antioxidant: a new role for RU-486 and related compounds. J Clin Invest 94:1990-1995.
67. Pascualy M, Petrie EC, Brodkin K, Peskind ER, Wilkinson CW, Raskind MA (2000) Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's disease. Biol Psychiatry 48:247-254.
68. Pasinetti GM, Lerner SP, Johnson SA, Morgan DG, Telford NA, Finch CE (1989) Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra. Brain Res Mol Brain Res 5:203-209.
69. Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A (2003) Comparative genome and proteome analysis of cerebral cortex from MK-801-treated rats. J Neurosci Res 7 1:526-533.
70. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. San Diego: Academic.
71. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A, Bah MJ, Dawood MY, Shah JD, Mark B, Kendall N, Smith MA, Saviolakis GA, Meyerhoff JL (2004) Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res 1025:10-20.
72. Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH (2004) Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125:1-6.
73. Rosenbrock H, Koros E, Bloching A, Podhorna J, Borsini F (2005) Effect of chronic intermittent restraint stress on hippocampal expression of marker proteins for synaptic plasticity and progenitor cell proliferation in rats. Brain Res 1040:55-63.
74. Rostworowski M, Balasingam V, Chabot S, Owens T, Yong VW (1997) Astrogliosis i the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. J Neurosci 17:3664-3674.
75. Samdani AF, Newcamp C, Resink A, Facchinetti F, Hoffman BE, Dawson VL, Dawson TM (1997) Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J Neurosci 17:4633-4641.
76. Sapolsky RM, Pulsinelli WA (1985) Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229:1397-1400.
77. Sapolsky RM, Krey LC, McEwen BS (1985) Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 5:1222-1227.
78. Seo DO, Rivier C (2001) Microinfusion of a nitric oxide donor in discrete brain regions activates the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 13:925-933.
79. Smith-Swintoski VL, Pettigrew LC, Sapolsky RM, Phares C, Craddock SD, Brooke SM, Mattson MP (1996) Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 16:585-598.
80. rd (1993) Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 52:135-142.
81. Sugo N, Hurn PD, Morahan MB, Hattori K, Traystman RJ, DeVries AC (2002) Social stress exacerbates focal cerebral ischemia in mice. Stroke 33:1660-1664.
82. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S (2004) Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 25:77-107.
83. Tomás-Camardiel M, Herrera AJ, Venero JL, Cano J, Machado A (2004) Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons: possible relevance to the etiology of Parkinson's disease. Curr Med Chem 4:223-233.
84. Tombaugh GC, Sapolsky RM (1992) Corticosterone accelerates hypoxia-and cyanide-induced ATP loss in cultured hippocampal astrocytes. Brain Res 588:154-158.
85. Tombaugh GC, Yang SH, Swanson RA, Sapolsky RM (1992) Glucocorticoids cxacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. J Neurochem 59:137-146.
86. Trentani A, Kuipers SD, Ter Horst GJ, Den Boer JA (2002) Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology? Eur J Neurosci 15:1681-1691.
87. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810-6818.
88. Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV (1998) Activation of p38MAPK in microglia after ischemia. J Neurochem 70:1764-1767.
89. Wellman CL (2001) Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 49:245-253.
90. Willard LB, Hauss-Wegrzyniak B, Wenk GL (1999) Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88:193-200.
91. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93:358-364.
92. Wilson RS, Barnes LL, Bennett DA, Li Y, Bienias JL, Mendes de Leon CF, Evans DA (2003) Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 64:380-382.
93. Woolley CS, Gould E, McEwen BS (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 531:225-231.
94. Xu H, Luo C, Richardson JS, Li XM (2004) Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenomics J 4:322-331.
95. Yokoyama C, Sasaki K (1999) Regional expressions of Fos-like immunoreactivity in rat cerebral cortex after stress; restraint and intraperitoneal lipopolysaccharide. Brain Res 816:267-275.
96. Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J 9:3545-3550.
97. Zafra F, Castren E, Thoenen H, Lindholm D (1991) Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci USA 88:10037-10041.